3647 results for «619»

Filter By

3647 results

Refining management of NSTEMI

21 May 2026 – From EuroPCR 2026

This session refines NSTEMI management by exploring advanced diagnostic tools, risk stratification, and tailored revascularization strategies, including bleeding risk assessment and dual antiplatelet therapy considerations.

Aneurysms and fistulas: contemporary approaches

21 May 2026 – From EuroPCR 2026

Focus on contemporary approaches to coronary aneurysms and fistulas, presenting complex interventional techniques and case-based strategies to overcome anatomical challenges and ensure effective treatment.

How to achieve coronary patency during TAVI

21 May 2026 – From EuroPCR 2026

This session addresses techniques to achieve coronary artery patency during transcatheter aortic valve implantation (TAVI), highlighting advanced procedural approaches and management of high-risk anatomical scenarios.

Sealing the deal: catheter based solutions for aortic disease

21 May 2026 – From EuroPCR 2026

Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure

03 Feb 2022

Didn’t find what you were looking for?